Elevation Oncology’s Post

🔬 Join Corina Dutcus, MD, SVP at Eisai, in a video interview discussing the phase 3 CLEAR study. Explore how lenvatinib pembrolizumab transform advanced ccRCC treatment. Watch here: [video]https://buff.ly/3u0FV4o Eisai USS ESMO - European Society for Medical Oncologyy

Oncology clinical research sites often encounter intricate challenges in budgeting for complex trials. Join us to review common billable items often overlooked in budgeting processes through the SCRS Site Invoiceables Toolkit. Gain practical knowledge to empower your site to navigate budget negotiations. Register here ⇢ https://lnkd.in/drGxcv4e

As the approach to therapies, particularly in the oncology space, becomes more comprehensive it's exciting to see collaboration across boundaries within the health care ecosystem. The role of hospitals, pharmacies and diagnostic centers and for that matter the roles of patients themselves have all expanded and become more interconnected to the end of increased viability of treatments. Thanks to Yuri Fesko MD, Vice President for Medical Affairs at Quest Diagnostics and his team for their thought leadership on the role of diagnostics via their recently published white paper. The summary linked below is worth the quick read, as is the white paper itself for a deeper dive. https://lnkd.in/eirDUk58

Oncology clinical research sites often encounter intricate challenges in budgeting for complex trials. Join us to review common billable items often overlooked in budgeting processes through the SCRS Site Invoiceables Toolkit. Gain practical knowledge to empower your site to navigate budget negotiations. Register here ⇢ https://lnkd.in/d-reDKKD

Congratulations ! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for successfully PUBLISHED the Observational study on Oncology molecule "Netupitant and Palonosetron" with 360 patients PAN India. #cro #clinicaldatamanagement #medicalwriting #clinicaloperations #OBSERVATIONALSTUDY #statisticalanalysis #clinicalresearch #clinicaltrials #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications #submission #manuscripts #REALWORLDSTUDY #doctors #regulatoryaffairs #projectmanagement #qualitycontrol #sitemanagement #medicaldevices #pharmaceuticalsindustry #lifesciences

OUT NOW: These 12 recent research studies showcase the power of real-world data to generate impactful insights, provide evidence for label expansion or line of therapy changes and expand our understanding of therapeutics. Get your copy today: https://hubs.la/Q02jY2WB0 #RWR #RWD #OncologyResearch

We think we have some pretty interesting findings here! TL;DR: FDA registration trials describing curative interventions, studies published in traditionally defined high-impact journals, and genitourinary trial publications tend to have the greatest Altmetrics. Maybe Toni Choueiri is single-handedly responsible for the GU Altmetrics?!?! Check it out #ASCO #CCI American Society of Clinical Oncology (ASCO)

AAMP Fall 2023 on Advanced Integrative Oncology, Oct 13-15 in Scottsdale, AZ. #CME Hybrid Conference with full flexibility: Attend In Person, Live Streaming, Post Conference, or any combination AND receive your CME credits. Excellent Faculty Speakers, Daily Clinical panel, workshops and cocktail reception. 18 CMEs, incl. 9 pharma and 2.75 Ethics credits. #CONO and @CNPBC applied for. Register: https://lnkd.in/etDxmBaU #cancertreatment, #integrativemedicine, #integrativeoncology, #naturopathicmedicine, #bonecancer, #prostatecancer, #breastcancer, #lungcancer, #cancertherapy, #bonedensity, #patientmanagement, #palliativecare

FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023 #CancerTreatment #ClinicalTrialData #DrugApproval #FDAOncology #Healthcare #MedicalResearch #OncoDaily #Oncology